394 related articles for article (PubMed ID: 24945909)
1. Spontaneous colitis in Muc2-deficient mice reflects clinical and cellular features of active ulcerative colitis.
Wenzel UA; Magnusson MK; Rydström A; Jonstrand C; Hengst J; Johansson ME; Velcich A; Öhman L; Strid H; Sjövall H; Hansson GC; Wick MJ
PLoS One; 2014; 9(6):e100217. PubMed ID: 24945909
[TBL] [Abstract][Full Text] [Related]
2. CD103+ CD11b+ Dendritic Cells Induce Th17 T Cells in Muc2-Deficient Mice with Extensively Spread Colitis.
Wenzel UA; Jonstrand C; Hansson GC; Wick MJ
PLoS One; 2015; 10(6):e0130750. PubMed ID: 26121642
[TBL] [Abstract][Full Text] [Related]
3. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis.
Johansson ME; Gustafsson JK; Holmén-Larsson J; Jabbar KS; Xia L; Xu H; Ghishan FK; Carvalho FA; Gewirtz AT; Sjövall H; Hansson GC
Gut; 2014 Feb; 63(2):281-91. PubMed ID: 23426893
[TBL] [Abstract][Full Text] [Related]
4. Biochanin a ameliorates DSS-induced ulcerative colitis by improving colonic barrier function and protects against the development of spontaneous colitis in the Muc2 deficient mice.
Zhang H; Wang X; Zhao L; Zhang K; Cui J; Xu G
Chem Biol Interact; 2024 May; 395():111014. PubMed ID: 38648921
[TBL] [Abstract][Full Text] [Related]
5. Macrophage and dendritic cell subsets in IBD: ALDH+ cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation.
Magnusson MK; Brynjólfsson SF; Dige A; Uronen-Hansson H; Börjesson LG; Bengtsson JL; Gudjonsson S; Öhman L; Agnholt J; Sjövall H; Agace WW; Wick MJ
Mucosal Immunol; 2016 Jan; 9(1):171-82. PubMed ID: 26080709
[TBL] [Abstract][Full Text] [Related]
6. Muc5ac Expression Protects the Colonic Barrier in Experimental Colitis.
Olli KE; Rapp C; O'Connell L; Collins CB; McNamee EN; Jensen O; Jedlicka P; Allison KC; Goldberg MS; Gerich ME; Frank DN; Ir D; Robertson CE; Evans CM; Aherne CM
Inflamm Bowel Dis; 2020 Aug; 26(9):1353-1367. PubMed ID: 32385500
[TBL] [Abstract][Full Text] [Related]
7. MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis.
Yao D; Dai W; Dong M; Dai C; Wu S
EBioMedicine; 2021 Dec; 74():103751. PubMed ID: 34902790
[TBL] [Abstract][Full Text] [Related]
8. Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis.
van der Post S; Jabbar KS; Birchenough G; Arike L; Akhtar N; Sjovall H; Johansson MEV; Hansson GC
Gut; 2019 Dec; 68(12):2142-2151. PubMed ID: 30914450
[TBL] [Abstract][Full Text] [Related]
9. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis.
Heazlewood CK; Cook MC; Eri R; Price GR; Tauro SB; Taupin D; Thornton DJ; Png CW; Crockford TL; Cornall RJ; Adams R; Kato M; Nelms KA; Hong NA; Florin TH; Goodnow CC; McGuckin MA
PLoS Med; 2008 Mar; 5(3):e54. PubMed ID: 18318598
[TBL] [Abstract][Full Text] [Related]
10. CD103+ Dendritic Cell Function Is Altered in the Colons of Patients with Ulcerative Colitis.
Matsuno H; Kayama H; Nishimura J; Sekido Y; Osawa H; Barman S; Ogino T; Takahashi H; Haraguchi N; Hata T; Matsuda C; Yamamoto H; Uchino M; Ikeuchi H; Doki Y; Mori M; Takeda K; Mizushima T
Inflamm Bowel Dis; 2017 Sep; 23(9):1524-1534. PubMed ID: 28700533
[TBL] [Abstract][Full Text] [Related]
11. Probiotic mixture VSL#3 reduces colonic inflammation and improves intestinal barrier function in Muc2 mucin-deficient mice.
Kumar M; Kissoon-Singh V; Coria AL; Moreau F; Chadee K
Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G34-G45. PubMed ID: 27856417
[TBL] [Abstract][Full Text] [Related]
12. Muc2 mucin O-glycosylation interacts with enteropathogenic Escherichia coli to influence the development of ulcerative colitis based on the NF-kB signaling pathway.
Wei J; Chen C; Feng J; Zhou S; Feng X; Yang Z; Lu H; Tao H; Li L; Xv H; Xuan J; Wang F
J Transl Med; 2023 Nov; 21(1):793. PubMed ID: 37940996
[TBL] [Abstract][Full Text] [Related]
13. Importance and regulation of the colonic mucus barrier in a mouse model of colitis.
Petersson J; Schreiber O; Hansson GC; Gendler SJ; Velcich A; Lundberg JO; Roos S; Holm L; Phillipson M
Am J Physiol Gastrointest Liver Physiol; 2011 Feb; 300(2):G327-33. PubMed ID: 21109593
[TBL] [Abstract][Full Text] [Related]
14. Muc2 Mucin and Nonmucin Microbiota Confer Distinct Innate Host Defense in Disease Susceptibility and Colonic Injury.
Leon-Coria A; Kumar M; Workentine M; Moreau F; Surette M; Chadee K
Cell Mol Gastroenterol Hepatol; 2021; 11(1):77-98. PubMed ID: 32659381
[TBL] [Abstract][Full Text] [Related]
15. Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative Colitis.
Sham HP; Bazett M; Bosiljcic M; Yang H; Luk B; Law HT; Morampudi V; Yu HB; Pankovich J; Sutcliffe S; Bressler B; Marshall JK; Fedorak RN; Chen J; Jones M; Gunn H; Kalyan S; Vallance BA
Front Immunol; 2018; 9():2211. PubMed ID: 30319652
[No Abstract] [Full Text] [Related]
16. The goblet cell-derived mediator RELM-β drives spontaneous colitis in Muc2-deficient mice by promoting commensal microbial dysbiosis.
Morampudi V; Dalwadi U; Bhinder G; Sham HP; Gill SK; Chan J; Bergstrom KS; Huang T; Ma C; Jacobson K; Gibson DL; Vallance BA
Mucosal Immunol; 2016 Sep; 9(5):1218-33. PubMed ID: 26813339
[TBL] [Abstract][Full Text] [Related]
17. Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core.
Hanski C; Born M; Foss HD; Marowski B; Mansmann U; Arastéh K; Bachler B; Papenfuss M; Niedobitek F
J Pathol; 1999 Jul; 188(3):304-11. PubMed ID: 10419600
[TBL] [Abstract][Full Text] [Related]
18. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
19. Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis.
Alipour M; Zaidi D; Valcheva R; Jovel J; Martínez I; Sergi C; Walter J; Mason AL; Wong GK; Dieleman LA; Carroll MW; Huynh HQ; Wine E
J Crohns Colitis; 2016 Apr; 10(4):462-71. PubMed ID: 26660940
[TBL] [Abstract][Full Text] [Related]
20. Correlations between colonic crypt mucin chemotype, inflammatory grade and Desulfovibrio species in ulcerative colitis.
Lennon G; Balfe Á; Bambury N; Lavelle A; Maguire A; Docherty NG; Coffey JC; Winter DC; Sheahan K; O'Connell PR
Colorectal Dis; 2014 May; 16(5):O161-9. PubMed ID: 24345279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
